BSPM.US Biostar Pharmaceuticals Inc

Healthcare Pharmaceuticals USA Stocks
0.0001 USD
Close of Nov 13, 2026
0.0001 0.0001
Market cap
USD 263.00
P/E
-
P/B
0.01x
ROE
-9.2%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2017.

Is BSPM.US undervalued?

Graham number

The Graham number of Biostar Pharmaceuticals Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Biostar Pharmaceuticals Inc fundamental analysis

No fundamental analysis for Biostar Pharmaceuticals Inc yet.

Biostar Pharmaceuticals Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Biostar Pharmaceuticals Inc

Biostar Pharmaceuticals, Inc. develops, manufactures, and markets pharmaceutical products for various diseases and conditions in the People's Republic of China. The company principally offers Xin Ao Xing Oleanolic Acid capsule, an OTC medicine for chronic hepatitis B. It also provides OTC products, such as Ganwang compound paracetamol and amantadine hydrochloride capsule for the relief of common cold, runny nose, sore throat, headache, and fever; Tianqi Dysmenorrhea capsule,…

Full company profile